or Try an Advanced Search...

    Treatment Of Breast Cancer Stocks List

    Symbol Grade Name % Change
    GLSI D Greenwich LifeSciences, Inc. -3.61
    PBYI D Puma Biotechnology Inc -4.94
    OLMA F Olema Pharmaceuticals, Inc. 2.16
    ZNTL F Zentalis Pharmaceuticals, Inc. 0.09
    PDSB F PDS Biotechnology Corporation -2.36
    CHRS F Coherus BioSciences, Inc. -2.20
    BCTX F BriaCell Therapeutics Corp. 0.44
    BPTH F Bio-Path Holdings Inc 3.83
    ICAD F icad inc. -2.72
    SBFM F Sunshine Biopharma Inc. 17.82
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies Software - Application
    Related Stock Lists: Breast Cancer Cancer Medicine Biotechnology Biopharmaceutical Clinical Medicine Her2 Her2/Neu Epidermal Growth Factor Receptor Immunotherapy Acid Advanced Breast Cancer Antiestrogens Estrogen Estrogen Receptor Hormones Lymphoma Oncology Prostate Cancer Selective Estrogen Receptor Degraders

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Breast Cancer stocks.

    Symbol Grade Name Weight
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 1.64
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 1.31
    CNCR D Loncar Cancer Immunotherapy ETF 1.05
    SBIO D ALPS Medical Breakthroughs ETF 0.87
    XBI D SPDR S&P Biotech ETF 0.77
    View all Treatment Of Breast Cancer ETFs...
    Compare ETFs
    Compare BBC to SBIO Compare BBC to XBI Compare LABD to XBI

        Treatment Of Breast Cancer Stocks Recent News

        Date Stock Title
        May 5 PBYI Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results
        May 5 PBYI Puma Biotechnology: A Story In Flux Heading Into Mid-2024
        May 4 PBYI Puma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        May 3 PBYI Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
        May 3 PBYI Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat
        May 3 PDSB PDS Biotechnology Announces Details of Virtual KOL Event
        May 3 PBYI Puma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...
        May 3 PBYI Puma Biotechnology, Inc. (PBYI) Q1 2024 Earnings Call Transcript
        May 2 PBYI Puma Biotechnology, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 2 PBYI Puma Biotechnology Inc (PBYI) Reports Q1 Financial Results, Misses Analyst Revenue and EPS Forecasts
        May 2 PBYI Puma Biotechnology Non-GAAP EPS of -$0.05 beats by $0.10, revenue of $43.8M misses by $5.25M
        May 2 PBYI Puma Biotechnology Reports First Quarter Financial Results
        May 2 PDSB PDS Biotechnology names Stephan Toutain as COO
        May 2 ICAD iCAD to Report First Quarter 2024 Financial Results on May 15, 2024
        May 2 PDSB PDS Biotech Appoints Stephan Toutain as Chief Operating Officer
        May 1 PBYI Puma Biotechnology Q1 2024 Earnings Preview
        May 1 CHRS Coherus to Report First Quarter 2024 Financial Results on May 9, 2024
        May 1 BPTH Looking Into Bio-Path Hldgs's Recent Short Interest
        May 1 OLMA Olema Oncology to Participate in Upcoming Investor Conferences in May
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies Software - Application
        Related Stock Lists: Breast Cancer Cancer Medicine Biotechnology Biopharmaceutical Clinical Medicine Her2 Her2/Neu Epidermal Growth Factor Receptor Immunotherapy Acid Advanced Breast Cancer Antiestrogens Estrogen Estrogen Receptor Hormones Lymphoma Oncology Prostate Cancer Selective Estrogen Receptor Degraders
        Treatment Of Breast Cancer

        Treatment of breast cancer depends on the type and stage of the cancer, as well as the patient's age, overall health, and personal preferences. Treatment options may include surgery, radiation therapy, chemotherapy, hormone therapy, targeted therapy, and/or immunotherapy.

        Browse All Tags